Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients
暂无分享,去创建一个
J. Cen | Qinrong Wang | Jinlan Pan | Suning Chen | Meng-xing Xue | Yuejun Liu | Ping Liu | Pin Wu | Xiao-hong Zhao | Z. Wang | Dandan Liu | Jiaqi Tan | Xiaomei Qi | Mengxing Xue